However, patients with PDL-1 expression >10% and high tumor mutation burden (TMB) had significantly higher ORRs compared with patients with PDL-1 expression below 1% (50.0% vs. 10.7%, p = 0.019) or low TMB (75.0% vs. 16.1%, p = 0.03). Here, CD274 is linked to neoplasm.